Lumanity

Therapeutic Science and Strategy

Science EN ↓ Епізодів: 27

In this podcast series, Joel Sandler, Principal, BioConsulting, Cancer Cell Therapy Lead, sits down with various guests to talk about important topics that impact the pharmaceutical, biotech, and medical device industries.

Автор

Lumanity

Категорія

Science

Сайт подкасту

sites.libsyn.com

Останній епізод

9 лип 2026

Де слухати?

Подкасти в застосунку Replaio Radio Уже незабаром

Подкасти незабаром з'являться в застосунку. Встановіть уже зараз і першими побачте зовсім новий погляд на подкасти

Встановіть безкоштовно Android майже 10 млн завантажень · рейтинг 4,8 iOS незабаром

Епізоди

CAR-T in Solid Tumors: A Cancer Progress Sneak Peek 25.04.2022 22:47

In this podcast series, Joel Sandler, Principal, Cancer Cell Therapy Lead, sits down to talk about relevant and important content. In this second episode, Joel sits down with Shivani Srivastava, PhD, Assistant Professor Human Biology Division, Fred Hutchinson Cancer Research Center , to explore: Key challenges to addressing solid tumors with cell therapy Recent developments (technology, scientifi...

Not So Rare: Win-wins in Ultra-orphan Diseases 25.02.2022 18:40

In this podcast series, Joel Sandler, Principal, Cancer Cell Therapy Lead, sits down to talk about relevant and important content. In this first episode, Joel sits down with Michael Parisi, CEO of Guidemark, and Michael Rice, Vice President, Head of Advanced Therapeutics, to explore: How uncovering NSCLC and SMA genetics led to record-speed options for patients with rare subtypes How the patient a...